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ABSTRAK
Penutupan ventricular septal defect (VSD) transkateter pada VSD perimembran dan VSD muskular saat 
ini sudah banyak dilakukan dan memliki banyak keuntungan dibandingkan dengan operasi. Pada VSD residual 
pasca-operasi penyakit jantung bawaan (PJB) kompleks, tindakan ini masih merupakan tantangan karena 
kelainan anatomi yang kompleks, stabilitas alat yang kurang sehingga perlu kecermatan untuk memilih teknik 
dan alat yang tepat.
Makalah ini melaporkan tindakan penutupan VSD residual pasca-operasi Rastelli pada pasien double 
outlet right ventricle (DORV), sub-aortic VSD, severe infundibulum pulmonary stenosis (PS) dan single arteri 
koroner. Pasien sudah menjalani empat kali operasi, namun masih ada VSD residual yang signifikan sehingga 
pasien mengalami gagal jantung yang tidak dapat dikontrol dengan obat. Pertama kali VSD residual ditutup 
menggunakan alat penutup VSD, namun setelah alat direlease, alat terlepas dan mengalami embolisasi ke aorta, 
alat dapat diambil kembali dengan snare. Kemudian VSD ditutup menggunakan alat penutup patent ductus 
arteriosus (PDA). Pasca-penutupan VSD, posisi alat stabil. Setelah tindakan, kondisi klinis membaik dan pasien 
dapat dipulangkan. Berdasarkan pengalaman ini, kami menyimpulkan bahwa metode transkateter menggunakan 
alat penutup PDA cukup efektif untuk menutup VSD residual pada PJB kompleks dengan hasil yang cukup baik.
Kata kunci: VSD residual, alat penutup PDA, penutupan transkateter, gagal jantung, Rastelli.
ABSTRACT
Transcatheter closure of perimembranous and muscular ventricular septal defect (VSD) has been performed 
widely and it has more advantages compare to surgery. However, transcatheter closure of residual VSD post 
operation of complex congenital heart disease is still challenging because of the complexity of anatomy and 
concern about device stability, so the operator should meticulously choose the most appropriate technique and 
device.
We would like to report a case of transcatheter closure of residual VSD post Rastelli operation in a patient with 
double outlet right ventricle (DORV), sub-aortic VSD, severe infundibulum pulmonary stenosis (PS) and single 
coronary artery. The patient had  undergone operations for four times, but he still had intractable heart failure 
that did not response to medications. On the first attempt. we closed theVSD using a VSD occluder, unfortunately 
the device embolized into the descending aorta, but fortunately we was able to snare it out. Then we decided to 
close the VSD using a patent ductus arteriosus (PDA occluder). On transesophageal echocardiography (TEE) 
and angiography evaluation, the device position was stable. Post transcatheter VSD closure, the patient clinical 
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condition improved significantly and he could finally be discharged after a long post-surgery hospitalization. 
Based on this experience we concluded that the transcatheter closure of residual VSD in complex CHD using 
PDA occluder could be an effective alternative treatment.
Key words: residual VSD, PDA occluder, transcatheter closure, heart failure, Rastelli.
INTRODUCTION
Transcatheter closure of post-operative 
residual ventricular septal defect (VSD) in 
complex congenital heart disease (CHD) is 
a challenge for interventional cardiologists. 
Challenges may include but are not limited to 
the complexity of the procedure, the difficulty 
in obtaining catheter access and pathways, the 
accuracy in choosing the device, and the stability 
of the device due to a high risk of embolization.1,2
Residual VSD after a cardiac surgery of 
complex CHD is quite common. It occurs 
because the surgery is performed while the heart 
is beating, so that the surgeon may not be able to 
ensure a perfect closure.3-5 Evaluation can only 
be done with transesophageal echocardiography 
when the patient is already off-bypass,6 thus, 
if a complete closure was not achieved, the 
patient must undergo re-operation. With current 
advances in cardiac interventions, the need for 
re-operation can be minimized.7-13
CASE ILUSTRATION
Our patient was a 22-year-old male with 
body weight of 55 kg, referred from Bali, with 
a chief complaint of cyanosis since birth. On 
physical examination, cyanosis was seen in the 
lips and tongue, but no dyspnea was observed. 
His first heart sound was normal and the second 
heart sound was single. The grade 3 out of 6 
systolic ejection murmur was best heard at the 
second intercostal space of the left parasternal 
line. Respiratory sounds were vesicular with 
no rhonchi. The abdomen was flat with good 
turgor and no hepatomegaly. Clubbed fingers 
were found on the extremities. Laboratory 
examination showed a hemoglobin level of 23.1 
g/dL, hematocrit 71.1%, leukocytes 9,210/uL, 
and platelets 420,000/uL. Right QRS axis and 
right ventricular hypertrophy were found on 
electrocardiogram, while the chest x-ray showed 
right ventricular hypertrophy with concave 
pulmonary segment and decreased pulmonary 
blood flow. Echocardiography showed double 
outlet right ventricle (DORV), sub-aortic VSD 
and severe infundibulum pulmonary stenosis. 
On cardiac catheterization, we identified a 
single sub-aortic VSD and both main arteries 
arising from the right ventricle. The patient 
was scheduled for total surgical correction, 
consisting of VSD closure with left ventricle-
aorta tunneling and right ventricular outflow tract 
(RVOT) repair with transannular patch.
During the operation, the surgeon found that 
the patient had only a single coronary artery, with 
the right coronary artery crossing in front of the 
RVOT, making the resection and transannular 
patching was not feasible to perform. So, the 
surgeon decided to perform a Rastelli procedure 
with implantation of a conduit to connect the 
right ventricle to the pulmonary artery. The VSD 
was closed by creating an intracardiac tunnel 
connecting the left ventricle and the aorta.
During post-operative care, the patient 
developed symptomatic  heart  fa i lure . 
Echocardiography revealed significant residual 
VSDs. The patient still experienced dyspnea, 
recurrent pleural effusion, and persistent heart 
failures, which did not respond to the anti-
heart failure drugs, including furosemide (20 
mg twice daily), spironolactone (25 mg twice 
daily), captopril (12.5 mg twice daily), and 
digoxin (0.125 mg twice daily). Therefore, the 
patient needed re-operation to close the residual 
VSDs. Re-operation was performed twice, but 
residual VSDs were still found and heart failure 
persisted. Based on a discussion with physicians 
and parents, he underwent a catheterization 
procedure to close the residual VSDs.
On catheterization, aortic pressure was 
78/46 mmHg (mean pressure 57 mmHg) 
and pulmonary artery pressure was 30/15 
mmHg (mean pressure 24 mmHg). Multiple 
residual VSDs were identified on left ventricle 
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angiography. We decided to close the VSD with 
a 10 mm symmetrical perimembranous device 
(Lifetech®). A Terumo® guide wire and Judkin 
Right® (JR) catheter were used in this procedure 
to locate and cross the VSD from the left 
ventricle to the right ventricle. Several attempts 
were made before successfully crossing the VSD. 
After the wire crossed the VSD, several attempts 
was made to engage it into the right atrium and 
then to the vena cava, but these attempts failed. 
We then advanced the wire into the pulmonary 
artery, after which it was snared and pulled out 
of the inferior caval vein to create an artery-
venous loop.
Over the guide wire, a delivery catheter 
was introduced into the inferior caval vein and 
advanced until its tip reached the ascending 
aorta. The JR catheter and guide wire were 
manipulated in such a way that it formed a loop, 
which slid into the left ventricle, so that the tip 
of the delivery catheter was positioned in the 
left ventricle. After the delivery catheter tip was 
positioned in the left ventricle, the guide wire 
was withdrawn. A VSD closure device which 
had been screwed into the tip of a delivery 
cable, was compressed inside a loading catheter, 
which then was introduced under the delivery 
catheter. The device, attached by screw to the 
delivery cable, was advanced until it reached 
the left ventricle. The left disk of the device was 
deployed first, then the whole system was pulled 
out until the left disk touched the ventricular 
septum. Then the right disk was opened in the 
right ventricle by pulling out the delivery system. 
After deployment, angiography was performed 
several times to check the device position before 
release, showing that the device fit stably across 
the defect. However, after release, the device 
embolized into the ascending aorta and then to 
the descending part near the iliac bifurcatio. We 
successfully snared and withdrew the device. By 
way of femoral arterial angiography, no damage 
to the right iliac artery was observed.
Using the same technique as described 
above, we re-crossed the VSD using a JR catheter 
and a Terumo® guide wire. We decided to close 
the VSD with a PDA closure device, because this 
device is longer and quite stable to engage to the 
VSD. Using the same technique, the delivery 
catheter over the guide wire was advanced until 
its tip reached the ascending aorta, then the guide 
wire was pulled out. The PDA closure device 
was attached by screw to the tip of the delivery 
cable, compressed inside a loading catheter and 
introduced into the delivery catheter. Initially, 
the retention disk was deployed in the ascending 
aorta, followed by pulling down the whole system 
until the retention disk was positioned below the 
aortic valve. Subsequently, the whole system was 
slowly pulled again until the side of the device 
touched the ventricular septum, followed by 
pulling the delivery catheter to open the body of 
the device. Transesophageal echocardiography 
(TEE) and angiography were performed to 
check the device position and stability, revealing 
good results. Then we released the device from 
the delivery cable, after which it still sat nicely 
across the defect. When the angiogram was 
repeated, the position was found to be stable, 
but other residual VSDs were identified. Our 
attempt to cross the other residual VSDs using 
a guide wire and a JR catheter was unsuccessful. 
Finally, we decided to end the procedure because 
we were concerned that further manipulation 
using the catheter would dislodge the implanted 
device. Moreover, after the biggest residual 
VSD was successfully closed, the pressure of 
the right ventricle decreased by half immediately 
afterwards, so that a further attempt to close other 
residual VSDs was considered unnecessary.
After the procedure, the patient was 
transferred directly to the ward without need 
for ICU care. He was clinically improved. His 
chest x-ray showed decreased cardiomegaly 
and no more pericardial effusion. The patient 
was discharged one week after the transcatheter 
closure procedure in good condition after having 
been hospitalized for almost 3 months.
DISCUSSION
Although cardiac interventions have 
developed in the last two decades, surgery 
remains to be the only definitive treatment for 
complex CHD.3-5 This patient had a complex 
CHD, consisting of DORV, subaortic VSD, 
and severe pulmonary stenosis. The definitive 
therapy for this kind of heart lesion is a total 
surgical correction to close the VSD with 
236
Mulyadi M. Djer                                                                                                               Acta Med Indones-Indones J Intern Med
tunneling from the left ventricle (LV) to the 
aorta, resecting and enlarging the RVOT with 
transannular patching.3-5 Because the patient had 
only one coronary artery, in which the branch of 
the right coronary artery crossed in front of the 
RVOT, a resection to enlarge the RVOT was not 
possible. For this reason, we decided to implant 
a conduit to connect the right ventricle to the 
pulmonary artery.
Post-operatively the symptoms of heart 
failure persisted because the residual VSDs did 
not respond to anti-heart failure drugs. VSD 
closure with LV-aorta tunneling frequently results 
in residual VSDs because of the difficulty in part 
of the VSD being located beneath the aortic valve 
region. Since the procedure is done while the 
heart is not beating, the surgeon cannot ensure 
a complete VSD closure. The confirmation can 
only be done when the heart is beating again, 
using TEE.6 Another possible cause for residual 
VSDs in our patient was the loss of stitches 
between the patch and the heart tissue. The 
patient’s persistent heart failure symptoms 
necessitated closure of the residual VSDs. The 
stitches were found to be loose during the second 
re-operation to close the residual VSDs, such that 
the surgeon had to do re-hecting. Subsequently, 
we still found significant residual VSDs causing 
persistent heart failure. Unfortunately, a third re-
operation still failed to close the VSDs.
Surgery had been the only definitive way 
to treat CHD before interventional cardiology 
became popular. Although surgery is effective in 
most cases, it is also very invasive because the 
movement of the heart must be stopped using a 
cardioplegic drug during the operation and blood 
circulation must be maintained by the heart-lung 
machine. The use of this machine is risky because 
the blood has to flow through an artificial vessel 
without an endothelial layer. Blood that comes 
into contact with this artificial vessel will be 
destroyed, releasing inflammatory mediators 
which can result in a systemic inflammation 
response syndrome (SIRS).3-5 Therefore, VSD 
closure by operation carries a high risk. This 
patient still had residual VSDs even though he 
had undergone three operations. Performing a 
fourth operation did not seem to be a good option, 
since it was a burden for the patient and his 
family and had a risk of a life-threatening event. 
Cardiological intervention was developed 
to deal with this kind of situation. It offers a 
technique to cure CHD without surgery, which 
is often effective, less invasive, and also poses 
a lower risk compared to surgery. Cardiac 
intervention is currently the treatment of choice 
for certain types of non-cyanotic CHD, such as 
VSD, ASD, PDA, and pulmonary valve stenosis 
or aortic stenosis.6-13 Cardiac intervention 
techniques have been reported to be effective 
for closing residual VSDs found after a complex 
CHD surgery.1,2 These findings encouraged us 
to perform the transcatheter closure of VSDs in 
our patient.
Transcatheter closure of residual VSDs 
after a complex CHD operation is actually 
more difficult because of the complexity of 
the procedure, the non-ideal defect shape, 
heart tissue fragility and poor device stability, 
rendering a high risk of embolization. It is, 
therefore, crucial to choose the appropriate 
device and size.1-2 Initially, a 10-mm symmetrical 
VSD perimembranous closure device was used 
in our patient. Although the stability of the 
device had been checked before it was released, 
it embolized to the aorta. Fortunately, the device 
was successfully withdrawn by a snare. One of 
the advantages of the transcatheter procedure 
is that the device can be pulled back if there is 
an embolization without resulting in significant 
damage to the vessel.
On the second attempt, we used a 12-mm 
PDA closure device to close the residual VSD. 
Some reports stated that a PDA closure device 
can be used to close residual VSDs because this 
device has a relatively longer size.1 After the 
residual VSD was closed in our patient, the right 
ventricular systolic pressure decreased by half. 
After the device had been released, it remained 
stable and did not embolize (Figure 1). The 
device looked stable on post-procedure serial 
angiogram, however, there were still many small 
residual shunt VSDs from other VSDs. We tried 
to cross the other residual VSDs, but we were 
unsuccessful and finally we decided to end the 
procedure considering the risk of dislodging 
the implanted device. Fortunately, the patient 
significantly improved clinically after his biggest 
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residual VSD was closed with the PDA closure 
device. The patient was finally discharged 
after prolonged hospitalization prior to the 
interventions. Previous reviews also reported 
good success rates of transcatheter closure of 
VSD using a PDA closure device.1,2
CONCLUSION
Transcatheter closure of post-operative 
residual VSD using a PDA closure device can 
be effective and serve as a good alternative for 
re-operation.
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Figure 1. PDA closure device looked stable on the VSD 
site (arrow sign).
